Bart specialises in European and Dutch regulatory matters concerning pharmaceuticals and biologicals. He advices on market access, regulatory data protection, rights and obligations under the Orphan Drug Regulation and the Paediatric Regulation, pricing and reimbursement and EU or national inspections and/or enforcement actions. Bart has extensive experience in administrative law as it pertains to procedures against administrative authorities such as the Ministry of Health, the Dutch Medicines Evaluation Board (College ter Beoordeling van Geneesmiddelen) and the Dutch Healthcare Authority (Nederlandse Zorgautoriteit). He has also represented clients in procedure before the European Courts.
Previously, Bart worked as senior legal counsel for a multinational Chemical and Life Sciences company and before that he was a judge in the
Administrative Section of the District Court of Amsterdam.